Overview / Abstract: |
Nonalcoholic fatty liver disease (NAFLD) is a potentially progressive spectrum of liver disorders that includes among its more severe forms nonalcoholic steatohepatitis (NASH).1 Closely associated with rising rates of obesity and metabolic syndrome, the prevalence of NAFLD and NASH continues to trend upward, suggesting that over the next decade, patients, clinicians, and health care systems will face an exponential increase in burdens associated with this underrecognized epidemic.2-4 In addition to having a strong foundation in current best practices for NAFLD/NASH management, clinicians involved in the care of patients with or at risk for NASH must be prepared to appropriately integrate newer noninvasive diagnostic modalities into patient workups and have a good understanding of the mechanisms of action, latest efficacy and safety data, and potential prescribing considerations for the numerous NASH therapies currently in late-stage development.5,6 During this Evidence-Based Best Practices™ program, expert faculty will use animated illustrations to highlight clinically relevant pathways in the complex pathophysiologic mechanisms of NAFLD and NASH; discuss current recommendations on the use of liver biopsy and complementary, noninvasive modalities for NASH diagnosis and staging; interpret the latest evidence for emerging NASH therapies; and, share their preferred risk-stratification strategies to predict prognoses, shape management decisions, and monitor disease progression.4-7 References |
Expiration |
Jan 24, 2019 |
Discipline(s) |
Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physician CME, Physician Assistant CME |
Format |
Online, Webinar / Webcast / Video |
Credits / Hours |
1.5 |
Accreditation |
ACCME, CE |
Presenters / Authors / Faculty |
Zobair M. Younossi, MD, MPH, FAASLD (Chair); Vlad Ratziu, MD, PhD; Mary E. Rinella, MD |
Sponsors / Supporters / Grant Providers |
This activity is supported by an educational grant from Allergan and jointly provided by Global Education Group and Integritas Communications. |
Keywords / Search Terms |
Integritas Communications, NASH, Nonalcoholic Steatohepatitis, Nonalcoholic fatty liver disease, NAFLD, Diagnosis, Treatment, obesity, metabolic syndrome, Evidence-Based Best Practices, Free CE, Free CME, Continuing Medical Education, CME, Continuing Education, CE, Younossi, Ratziu, Rinella, video, webcast |